baber/WOPTO huggingface dataset:
Patent NZ-506604-A (NZ)
Title: HiB/DTPa vaccine composition and method of preparation
Inventor: ARTOIS CLAUDE
IPC: A61K39/095
Filed: 1999-03-22
Abstract: Method by which either extemporaneously prepared or liqui Hib/DTPa combination vaccines can be made in order to avoid Hib interference whilst being able to maintain the maximum, stable adsorption of each antigen onto the aluminium-based adjuvant on which it is most immunogenic. In so doing, pertussis antigens in combination vaccines are stably retained in their most potent form.
Patent NZ-518258-A (NZ)
Title: Resorbable bone plate
Inventor: CURTIS RAYMOND
IPC: A61B17/80
Filed: 1999-12-06
Abstract: Bone plate of longitudinal shape having an upper surface, a curved lower surface for contracting a bone, a plurality of conical through holes connecting the upper surface with the lower surface for receiving bone screws, a central longitudinal axis and consisting of a resorbable material, wherein A) the curved lower surface has a radius of curvature R which is smaller than 10mm; B) the ratio F/d of the total area F of the upper surface including the surface area of the through holes to the thickness d of the plate is in the range of 190 to 270 mm; and C0 the central part of the longitudinal plate has a generally constant width B whereas the width of the free ends of the longitudinal plate is narrowing to value b<0.3 B.
Patent NZ-520704-A (NZ)
Title: Male tissue-preferred regulatory region and method of using same
Inventor: ALBERTSEN MARC C
IPC: C07K14/415
Filed: 2001-02-13
Abstract: An isolated male-tissues preferred regulatory element consisting of a nucleotides sequence of at least 100 contiguous base pairs of the sequence extending from base 1 to a base 1311 of SEQ ID NO:1 or 2 is essential for initiating transcription of the MS45 gene. Expression vectors comprising the element can be used in methods for mediating or preventing male fertility in a plant. Transformed plants cells are also and methods of producing hybrid plants are also disclosed.
Patent NZ-522193-A (NZ)
Title: Data translation apparatus in mobile communication system connecting an ATM controller (ATM BSC) to IP base station transceivers (IP BTS)
Inventor: JEONG CHANG-RAE
IPC: H04W92/00
Filed: 2002-10-23
Abstract: A data translation apparatus is between a base station using an Internet protocol (IP) and a cell controller using an asynchronous transfer mode (ATM) data in a mobile communication system. The apparatus includes a plurality of line interface devices for performing a data connection with the cell controller, a physical layer processor for performing a data connection with the cell controller, a physical layer processor for performing a physical layer process on a data received through the line interface device, a universal test and operations physical layer protocol interface for ATM (UTOPIA) switch for performing a switching process for translating an transmitting ATM data received from a cell controller and data received from an IP base station, a data translator for translating data to be transmitted to the UTOPIA switch into asynchronous transfer mode adaption layer 0 (AAL0) data, and for translating data to be transmitted to the IP base station into Ethernet data, a plurality of repeaters for transceiving data between the IP base station and the data translator, a UTOPIA mapper for performing a UTOPIA interface on the data from the UTOPIA switch, a layer converter for converting the data from the UTOPIA interface to AAL0 layer or AAL2 layer data, and a controller for controlling operations of the layer converter, the UTOPIA mapper and the UTOPIA switch.
Patent NZ-524347-A (NZ)
Title: Textile product incorporating illuminated fibres, which are filaments and/or optical fibres with current supplied by an electric battery housed in a pocket of the article itself
Inventor: GIVOLETTI MARCELLO
IPC: D02G3/44
Filed: 2001-08-03
Abstract: Textile product comprising light guiding fibres (2) consisting of a central core capable of transmitting the light and of an external sheath, in which at least a length portion of the external sheath presents, in respect to the internal core, a refraction index allowing the transmitted light to partially escape from the fibre; cloth article made from the textile product; and a manufacturing method of the textile product. As illustrated by the weave scheme depicted, among the warp threads, only the fibres (2) are not interwoven by a suitable number (m1) of texture threads (3).
Patent NZ-526706-A (NZ)
Title: Use of inhibitor of differentiation markers ID-1 and ID-3 for the diagnosis and prognosis of prostate cancer
Inventor: GILLIS KIMBERLY A
IPC: C12Q1/68
Filed: 2001-11-28
Abstract: Described are compositions, kits and methods for detecting, characterizing, preventing, and treating prostate cancer. ID markers are provided, wherein changes in the levels of expression in a sample from a subject of one or more of the ID markers is correlated with the presence of prostate cancer.
Patent NZ-530584-A (NZ)
Title: HMG-COA reductase inhibitor extended release formulation
Inventor: CHEN CHIH-MING
IPC: A61K9/36
Filed: 2000-11-03
Abstract: A controlled release oral solid dosage form comprising lovastatin and a controlled release carrier, said dosage form increasing the bioavailability of lovastatin but not lovastatin acid when compared to the same amount of lovastatin administered in an immediate release dosage form, the dosage form also providing a reduction in serum cholesterol levels.
Patent NZ-533014-A (NZ)
Title: A system for sealing the secondary flow at the inlet to a nozzle of a turbomachine having a post-combustion chamber
Inventor: LAPERGUE GUY
IPC: F16J15/08
Filed: 2004-05-19
Abstract: An aviation turbomachine comprising, downstream from the turbine, a post-combustion chamber extended by at least one nozzle, said chamber being defined radially by a thermal protection lining disposed inside a casing, said casing and said lining together defining an annular channel in which, in operation, there flows a secondary flow, an annular diaphragm secured to said casing being disposed at the downstream end of said channel, said nozzle comprising a plurality of flaps hinged to the upstream end of said casing, each flap being fitted on its inside face with a thermal protection plate co-operating with said flap to define a passage for being fed with cooling air delivered by said diaphragm, wherein the feed of cooling air to said passages is provided by an annular duct defined on the outside by a first flexible annular gasket retained, in operation, pressed in sliding contact against the downstream inside face of the casing and against the upstream inside faces of the flaps under urging from the pressure of the secondary flow, and defined on the inside by a second flexible annular gasket whose upstream end is fixed to the radially inner zone of the diaphragm, and whose downstream end is pressed in sliding contact against the upstream inside face of the protection plates.
Patent NZ-539226-A (NZ)
Title: T cell receptor display
Inventor: JACOBSEN BENT KARSTEN
IPC: A61K38/00
Filed: 2003-10-30
Abstract: Provided is a phage particle displaying on its surface a dimeric T-cell receptor (dTCR) polypeptide pair or single chain TCR (scTCR) polypeptide, the said dTCR polypeptide pair being constituted by a first polypeptide wherein a TCR alpha or delta chain variable domain sequence is fused to the N terminus of a TCR alpha chain constant domain extracellular sequence, and a second polypeptide wherein a TCR beta or gamma chain variable domain sequence is fused to the N terminus of a TCR beta chain constant domain extracellular sequence, the first and second polypeptides being linked by a disulfide bond which has no equivalent in native alpha beta or gamma delta T cell receptors; the said scTCR polypeptide being constituted by a first segment constituted by a TCR alpha or delta chain variable domain sequence fused to the N terminus of a TCR alpha chain constant domain extracellular sequence, a second segment constituted by a TCR beta or gamma chain variable domain fused to the N terminus of a TCR beta chain constant domain extracellular sequence, a linker sequence linking the C terminus of the first segment to the N terminus of the second segment, or vice versa, and a disulfide bond between the first and second segments, said disulfide bond being one which has no equivalent in native alpha beta or gamma delta T cell receptors; and wherein the said disulfide bond in the dTCR polypeptide pair or scTCR polypeptide is between pairs of cysteine residues substituted for specified amino acids in specific pairs of positions. Further provided are similar phage particles with truncated TCR, libraries of phage particles and methods of identification of TCRs using said libraries.
Patent NZ-541411-A (NZ)
Title: Technology evaluating device, technology evaluating program, and technology evaluating method
Inventor: MASUYAMA HIROAKI
IPC: G06F17/30
Filed: 2003-12-26
Abstract: An information acquisition device comprises: a keyword collection means for collecting prescribed keywords from the technical literature; a count means for counting the number of technical literatures containing the prescribed keywords from a database population storing the technical literatures, a total count means for figuring out a total of technical literatures in the database population, a similarity rate calculation means for calculating a similarity rate based on the proportion of the technical literatures containing the prescribed keywords thus figured up to the total number of technical literatures in the database population, and an output means for outputting the similarity rate thus calculated to one or more of a display means, a record means and transmitting means.
Patent NZ-541880-A (NZ)
Title: Inverting vacuum panels for a plastic container
Inventor: LANE MICHAEL
IPC: B65D79/00
Filed: 2004-02-10
Abstract: A sidewall portion (18) of a plastic container (10) adapted for vacuum pressure absorption is disclosed. The sidewall portion includes generally rectangular shaped vacuum panels (32) equidistantly spaced about the container. The vacuum panels are defined in at least part by an upper portion (60), a central portion (62) and a lower portion (64) formed in a compound curve shape. The vacuum panels are moveable to accommodate vacuum forces generated within the container thereby decreasing the volume of the container.
Patent NZ-542875-A (NZ)
Title: Nucleic acid fragments encoding amino acid sequences (CADL2) for lignifications-related enzymes in plants, and the use thereof for the modification of plant cell walls and/or defence response in plants
Inventor: SPANGENBERG GERMAN
IPC: A01H5/00
Filed: 2004-05-07
Abstract: Described are polynucleotides encoding cinnamyl alcohol dehydrogenase 2-like (CAD2L) polypeptides. CAD2L polypeptides are produced in a plant in the same organs and the same developmental stages and processes as CAD2 and are likely to be involved in the same developmental processes as CAD enzymes. They can be used for modification of, for example, lignification, cellulose degradation, plant cell walls or plant defence response.
Patent NZ-543820-A (NZ)
Title: Anti-rotational hitch ball
Inventor: IRGENS CHRIS
IPC: B60D1/06
Filed: 2004-06-28
Abstract: A hitch assembly is disclosed that includes an anti-rotation mechanism. The hitch assembly generally includes a hitch ball, a ball mount, and a fastener. The disclosure is directed to a mechanism for preventing rotation of either the hitch ball or the fastener relative to the ball mount. The anti-rotation mechanism of the present disclosure provides an engagement means for interlocking sections of the hitch ball or fastener with the ball mount, thereby blocking rotation of the hitch ball or fastener relative to the ball mount.
Patent NZ-546902-A (NZ)
Title: Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
Inventor: RAO DHARMARAJ RAMACHANDRA
IPC: C07C211/42
Filed: 2004-11-04
Abstract: Disclosed are the processes for the preparation of sertraline hydrochloride forms II, III, IV or V by a) suspending/dissolving sertraline acetate in suitable solvents; b) adjusting the pH of the mixture to a value from 1 to 2 with hydrogen chloride gas at elevated temperatures as specified in the specification; c) cooling the reaction mixture as specified in the specification d) isolating the drying under vacuum at a temperature specified in the specification to obtain sertraline hydrochloride forms II, III, IV or V, the form achieved depending on the temperatures used in steps b-d.
Patent NZ-548279-A (NZ)
Title: Needleless access vial
Inventor: ENERSON JON R
IPC: A61B19/00
Filed: 2004-12-20
Abstract: A needleless access vial, comprising in combination: a vial; a valve for sealing the vial, the valve comprising a valve element positioned in a valve body; a retainer positioned about the valve body, valve element and a portion of the vial to sealingly sandwich the valve element between the portion of the vial and the valve body; and the valve element comprising a central passageway including a slit formed therein for receiving a neck of an access device such as a syringe.
Patent NZ-548394-A (NZ)
Title: A flat primary & secondary locking system
Inventor: SUTHERLAND ROBERT L
IPC: B65D71/00
Filed: 2005-02-25
Abstract: A secondary locking system for article carriers consisting of at least one secondary male lock (70A-C) with two shoulders that is attached by a neck to the edge of a outer flap (12) on the carrier for use with a primary locking system. An inner flap (26) has a secondary female opening (74A-C) for each secondary male lock. The secondary female opening is formed by a secondary cut line (76A-C) and fold line (84A-C) with the center of the fold line projecting towards the edge of the flap while of the center of the secondary cut line projects away from the edge of the flap to guide the secondary male lock into a flat position against the inside of the inner flap. The shoulders on the secondary male lock are engaged against locking ledges along the extensions of the secondary cut line. A pair of slits (86A-F) may be formed at the end of the fold lines that project inwardly to allow the secondary male lock to slide into a flat position. This locking system is especially useful in wrapping containers that have a flat bottom that would interfere with conventional locking systems.
Patent NZ-550341-A (NZ)
Title: Sustained-release oral molsidomine compostion for treating atherosclerosis
Inventor: GECZY JOZSEF-MICHEL
IPC: A61P9/10
Filed: 2005-04-01
Abstract: Disclosed is the use of molsidomine, or one of its pharmaceutically acceptable salts, in the form of a sustained-release solid oral composition effective over 24 hours, for the manufacture of a drug for preventing or attenuating the development of atherosclerosis.
Patent NZ-563045-A (NZ)
Title: Oral hygiene implement
Inventor: HSU WALTER
IPC: A46B9/04
Filed: 2005-10-28
Abstract: An oral hygiene implement 10 with a brush 20 on one end, a tapered wedge 16 on the other end and a grip in between. The brush 14 has a planar array of bristles mounted on a hollow shaft, with the longest bristles 34 being in the centre, and with the length of the bristles becoming progressively shorter as either end of the brush is approached. The tapered wedge 16 has along its length a central spine 38 and a pair of sloped lateral flanks 40 42 extending from the spine and intersecting along an edge 44 which intersects the spine at the pointed tip 46. An array of transverse trihedral ribs 50 projects from each flank of the tapered wedge. Each of the transverse trihedral ribs 50 has a scraping edge for use against proximal tooth surfaces.
Patent NZ-564097-A (NZ)
Title: Dried and/or microencapsulated saccharomyces cerevisiae cells with a high content of (S)-(+)-S-adenosyl-L-methionine, process for their preparation, and compositions containing said cells
Inventor: BENEDETTI ALBERTO
IPC: A61K36/064
Filed: 2006-06-09
Abstract: Disclosed is a pharmaceutical composition (such as a tablet, a gastroresistant tablet or a capsule) containing: (a) dried and/or microencapsulated Saccharomyces cerevisiae cells wherein (R)-(+)-(S)-adenosyl-L-methionine is in a quantity lower than or equal to 10% of (S)-(+)-S-adenosyl-L-methionine, said (S)-(+)-adenosyl-L-methionine being in the form of a free base obtainable from strains of Saccharomyces cerevisiae having a (S)-(+)-S-adenosyl-L-methionine productivity of 2.0-6.0% w/dry w at the end of fermentation and 7-20% w/dry w at the end of an enrichment stage, and (b) suitable excipients, in dried form or in microencapsulated form.
Patent NZ-574756-A (NZ)
Title: 2-aminobenzoxazole carboxamides as 5ht3 modulators
Inventor: FAIRFAX DAVID J
IPC: A61K31/423
Filed: 2007-08-07
Abstract: Disclosed are 2-aminobenzoxazole carboxamide compounds represented by formulas (I), (II) and (III), provided that the compound is not endo-N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-yl)-2-morpholinobenzoxazole. Also disclosed is the use of the said compounds for the manufacture of a medicament for treating a disorder which is dependent upon modulation of the serotonin type 3 receptor. A method of treating a disorder which is dependent upon modulation of the serotonin type 3 receptor, which comprising administering the said compounds to a non-human patient is also disclosed.
Patent NZ-577308-A (NZ)
Title: Method and system for manufacture of containers
Inventor: DAFFURN PAUL
IPC: B65D43/00
Filed: 2009-05-29
Abstract: A container 100 comprises a base portion 101 with an opening and a rim 104 proximate the opening, a lid portion 102 at least partially extendible across the opening, the base portion 101 and the lid portion 102 being made separately, an engagement portion adapted to provide coupling between the lid 102 and base 101 and located substantially at the rim 104 of the container 101, and a hinge region 108 enabling the lid 102 and base 101 to move relative to each other. The engagement portion is formed by at least a portion of an edge of the lid 102 and a recess defined by an outer surface of the base 101 and an inner surface of the rim 104.
Patent NZ-581401-A (NZ)
Title: A system for facilitating, recording and disbursing donations to charities and philanthropic projects
Inventor: STREMLER TROY
IPC: G06Q20/00
Filed: 2008-04-24
Abstract: Disclosed is a computer-implemented system (100) for securely funding charities (170). The system (100) includes an internet-enabled donor and charity management system (105), at least one donor funding link, at least one pay card funding link, at least one pay card (180) and at least one pay card transaction database (167). Donors (155) can donate to a philanthropic project (175) using the donor funding link. The at least one pay card (180) is associated with the philanthropic project (175) and is a stored value card. Donations can be transmitted to the pay card (180) using the at least one pay card funding link. Pay card transactions can be captured, stored and associated with the philanthropic project (175) in the at least one pay card transaction database (167).
Patent NZ-584868-A (NZ)
Title: Customer-defined account management rules for improved linked financial institution account management
Inventor: GHOSH DEBASHIS
IPC: G06Q40/02
Filed: 2010-04-23
Abstract: A method and an apparatus for managing financial institution accounts for managing financial institution accounts are disclosed. The apparatus (102) comprises a computer platform (104) including at least one processor (106) and a memory (108); a customer profile database (122) stored in the memory; an account linking module (112) stored in the memory, an account rules module (114) stored in the memory and an account management module (118) stored in the memory. The account linking module is executable by the at least one processor, and operable to receive one or more financial institution account linking requests and provide for one or more financial institution links. Each link provides for linking two or more financial institution accounts associated with a customer and one or more of the link requests provide for linking financial institution accounts associated with more than one financial institution. The account rules module is executable by the at least one processor, and operable to receive one or more customer-defined account rules associated with two or more of the linked financial institution accounts and store the rules in a customer profile associated with the customer. At least one of the customer defined account rules is operable to maximize the customer's rate of return associated with the two or more of the linked financial institution accounts by establishing a maximum balance limit. The account management module is executable by the at least one processor, and operable to manage funds in the plurality of financial institution customer accounts based on the account rules and including, account balance need logic operable to automatically and dynamically establish the maximum account balance based on logically determining, from historical account activity, one or more recurring debits and an amount and payment time associated with each recurring debit.
Patent NZ-587505-A (NZ)
Title: Method for preparing combretastatin
Inventor: FREDERIC MARC
IPC: C07C213/10
Filed: 2009-02-27
Abstract: Disclosed herein is a method for preparing a combretastatin (A) in the form of a base or of an addition salt with an acid; consisting in: · coupling, in the presence of an organic solvent, a base and T3P of formula (III), the (Z)-amino compound or the salt of the (Z)-amino compound, wherein B- denotes a counterion, with a doubly protected L-serine derivative of formula (II), in which PG denotes a group protecting the amine function, so as to obtain the compound of formula (Z)-IIb) · then in deprotecting and opening the ring of (Z)-(Ib) in the presence of an acid, so as to obtain the combretastatin of formula (A) in the form of a salt; · and, optionally, in adding a base so as to obtain the combretastatin of formula (A) in the form of a base, the salt of the (Z)-amino compound having been obtained by enrichment of the salt of the amino compound consisting of: o adding benzyl alcohol to a suspension of a mixture of the salts of the (Z)- and (E)--amino compounds in acetonitrile, then o mechanically separating the salt of the amino compound enriched in (Z) isomer.
Patent NZ-593301-A (NZ)
Title: Drive mechanism for a medication delivery device with a stop member preventing rotation of the drive member during dose setting
Inventor: NZIKE PHILIPPE
IPC: A61M5/24
Filed: 2009-12-09
Abstract: A drive mechanism (3) for a medication delivery device is disclosed. The drive mechanism comprises a housing (17) and a rotation member (34) adapted to be rotated in a first direction during setting of a medication dose and to be rotated in a second direction during delivery of the dose. A drive member (20) follows rotation the rotation member in the second dose delivery direction and a stop member (26) prevents rotation of the drive member (20) in the first direction when setting the dose. A piston rod (12) is adapted to be displaced in a distal direction by rotation of the drive member (20) in the second direction which is converted into rotation of the piston rod (12).
Patent NZ-599429-A (NZ)
Title: Modified oil encapsulating proteins and uses thereof
Inventor: ROBERTS NICHOLAS JOHN
IPC: C07K14/415
Filed: 2010-10-29
Abstract: Disclosed is a polynucleotide encoding a modified oleosin including at least one artificially introduced cysteine, wherein the cysteine is introduced in at least one of: a)the N-terminal hydrophilic region of the oleosin, and b)in the C-terminal hydrophilic region of the oleosin. Also disclosed is a method of producing a plant that accumulates more oil than a suitable control plant, the method comprising providing a plant transformed with a polynucleotide as defined in the complete specification that expresses modified oleosin encoded by said polynucleotide.